Inventor
PELUSO STEPHANE
US26 patents
⚠️ This page may combine multiple inventors who share the name “PELUSO STEPHANE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INFINITY PHARMACEUTICALS INC
7 patentsUS7812164B2Oct 12, 2010
Cyclopamine analogs
INFINITY PHARMACEUTICALS INC84 citations99
US10406139B2Sep 10, 2019
Cyclopamine analogs
INFINITY PHARMACEUTICALS INC8 citations92
US9492435B2Nov 15, 2016
Cyclopamine analogs
INFINITY PHARMACEUTICALS INC13 citations92
US9951083B2Apr 24, 2018
Cyclopamine analogs
INFINITY PHARMACEUTICALS INC4 citations84
US11007181B2May 18, 2021
Cyclopamine analogs
INFINITY PHARMACEUTICALS INC1 citations73
US9346769B2May 24, 2016
Tetrazolones as inhibitors of fatty acid synthase
INFINITY PHARMACEUTICALS INC2 citations61
US9630979B2Apr 25, 2017
Inhibitors of monoacylglycerol lipase and methods of their use
INFINITY PHARMACEUTICALS INC0 citations52
MILLENNIUM PHARM INC
6 patentsUS8008307B2Aug 30, 2011
Heteroaryl compounds useful as inhibitors of E1 activating enzymes
MILLENNIUM PHARM INC25 citations91
US8901136B2Dec 2, 2014
Heteroaryl compounds useful as inhibitors of E1 activating enzymes
MILLENNIUM PHARM INC12 citations90
US9150525B2Oct 6, 2015
Heteroaryl compounds useful as inhibitors of E1 activating enzymes
MILLENNIUM PHARM INC10 citations83
US7951810B2May 31, 2011
Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of E1 activating enzymes
MILLENNIUM PHARM INC16 citations83
US9458108B2Oct 4, 2016
Heteroaryl compounds useful as inhibitors of E1 activating enzymes
MILLENNIUM PHARM INC3 citations72
US9718788B2Aug 1, 2017
Heteroaryl compounds useful as inhibitors of E1 activating enzymes
MILLENNIUM PHARM INC0 citations51
CASTRO ALFREDO C
4 patentsUS8609706B2Dec 17, 2013
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
CASTRO ALFREDO C0 citations51
US8304428B2Nov 6, 2012
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
CASTRO ALFREDO C0 citations51
US8178690B2May 15, 2012
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
CASTRO ALFREDO C0 citations51
US7745464B2Jun 29, 2010
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
CASTRO ALFREDO C0 citations51
BEHNKE MARK L
3 patentsUS9149465B2Oct 6, 2015
Isoxazolines as inhibitors of fatty acid amide hydrolase
BEHNKE MARK L0 citations49
US8765735B2Jul 1, 2014
Isoxazolines as inhibitors of fatty acid amide hydrolase
BEHNKE MARK L1 citations49
US8927551B2Jan 6, 2015
Isoxazolines as inhibitors of fatty acid amide hydrolase
BEHNKE MARK L0 citations39